Some authors have focused on establishing a specific treatment for complex regional pain syndrome by studying the role of receptor tyrosine kinase for NGF in patients with CIPA [29]. The gene discussed is NTRK1; the disease is hereditary sensory and autonomic neuropathy type 4.